Erratum: Oral intake of royal jelly improves anti-cancer effects and suppresses adverse events of molecular targeted therapy by regulating TNF-α and TGF-β in renal cell carcinoma: A preliminary study based on a randomized double-blind clinical trial

Mol Clin Oncol. 2020 Dec;13(6):78. doi: 10.3892/mco.2020.2148. Epub 2020 Sep 25.

Abstract

[This corrects the article DOI: 10.3892/mco.2020.2099.].

Publication types

  • Published Erratum